BBTV

About Us

Biotech in the Money

all episodes

Biotech in the Money, May ’10 Edition

  1. Why the Paradigm Shift at the FDA, over the Past 5 Years?
  2. Is Anything Binding With the FDA Anymore, or Are Companies Just Not Listening?
  3. Chronic Disease vs. Critical Needs: the FDA Fast Track, and Recourses for Companies
  4. Biosimilars are Without a Champion at the FDA
  5. FDA Very Actively Enforcing Compliance Regulation
  6. If You Had Unlimited Powers, How Would You Reform the FDA?
  7. Combination Therapy in the Eyes of the FDA. Can We Let FDA Off the Hook? The System Return to a More Rational Process

Biotech in the Money, March ’10 Edition

  1. The OSIP / Astellas Saga
  2. The 2010 Biotech IPO Review, 1st Quarter
  3. Medivation’s Phase 3 is a Total Bust. Will Dimebon get a Second Life?
  4. Xenoport’s Phase 3, Also a Bust. An Eleventh-hour FDA Decision?
  5. Good News of the Month : Acorda and Viropharma, Stories with Upside
  6. Big Pharma’s Cancer Setbacks, Arrr You Hungry for More Biotech?
  7. Shareholder Activism : What Carl Icahn Can and Cannot Do with Genzyme
  8. Next Month in Biotech, Events to Look Out For

  • Categories

    • Shows
      • Biotech in the Money
      • Wall Street on BBTV
      • Science Breakthrough
      • The Jan Buck Show
      • 60sec Pitches
      • Special Interview
      • Report on Location
      • Wall Street
    • Series
      • The Stem Cell Review
      • Alzheimer's Today
      • The MedTech Report
      • Stem Cell Review
    • Channels
      • Science
      • Finance
      • Business
    • About
      • about sub
      • about sub 2

  • Acknowlegments

    nasdaq nasdaq

  • About the Series

    The Stem Cell Review is a 10-part original series on the science, medical applications, and business of stem cells.

    This program will give you a clear and concise understanding of the state of stem cells today, with the additional depth and expertise you would come to expect from the most renown authorities in the field.

    The Stem Cell Review is a BioBusiness.TV Original Program, presented by Bill Kridel, produced by Jean-Loup Romet-Lemonne and Jonathan Teper.

  • Channels
    • Science
  • Series
    • The Stem Cell Review
  • Shows
    • Biotech in the Money
    • Report on Location
    • Science Breakthrough
    • Special Interview
    • The Jan Buck Show
    • Wall Street
    • Wall Street 2
    • Wall Street on BBTV
  • About
    • about sub
    • about sub 2